Ahmed A. Kolkailah

Brown University — United States

Medicine · Health Sciences

17h-index1.1kcitations81works3.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cardiac Valve Diseases and Treatments(22), Diabetes Treatment and Management(17), Infective Endocarditis Diagnosis and Management(16), Metabolism, Diabetes, and Cancer(10), Venous Thromboembolism Diagnosis and Management(7)

Publications81 total

Will a Conservative Case Selection Strategy Improve Hospital-Level TAVR Performance Metrics?
Circulation Cardiovascular Interventions·2025
Coronary Artery Revascularization in the Older Adult Population: A Scientific Statement From the American Heart Association
Circulation·2025Open Access
Heart Failure Outcomes Captured by Adverse Event Reporting in Participants with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Observations from the VERTIS CV Trial
European Journal of Heart Failure·2025· 1 citedOpen Access
Standard- versus extended-duration anticoagulation for primary venous thromboembolism prophylaxis in acutely ill medical patients
Cochrane Database of Systematic Reviews·2024· 4 citedOpen Access
Hypoglycemia and Cardiovascular Outcomes in the CARMELINA and CAROLINA Trials of Linagliptin
JAMA Cardiology·2024· 14 citedOpen Access
Automated External Defibrillator Use After Out-of-Hospital Cardiac Arrest at Recreational Facilities
JAMA Internal Medicine·2024· 3 citedOpen Access
Abstract 340: Automated External Defibrillator Utilization After Out-of-Hospital Cardiac Arrest at Recreational Facilities in the United States
Circulation·2023
Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial
European Heart Journal·2023· 3 citedOpen Access
Gaps in Guideline-Based Lipid-Lowering Therapy for Secondary Prevention in the United States: A Retrospective Cohort Study of 322 153 Patients
Circulation Cardiovascular Quality and Outcomes·2023· 43 citedOpen Access
Highlights From the <i>Circulation</i> Family of Journals
Circulation·2023Open Access
Longitudinal Trends in Cardiovascular Risk Factor Profiles and Complications Among Patients Hospitalized for COVID-19 Infection: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry
Circulation Cardiovascular Quality and Outcomes·2023· 12 citedOpen Access
Uptake of non-statin lipid-lowering therapies for secondary prevention in community practice
Journal of clinical lipidology·2023· 13 cited
HEART FAILURE OUTCOMES CAPTURED BY ADVERSE EVENT REPORTING IN PARTICIPANTS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: OBSERVATIONS FROM THE VERTIS CV TRIAL
Journal of the American College of Cardiology·2023
Incident and recurrent hypoglycaemia with linagliptin and glimepiride over a median of 6 years in the <scp>CAROLINA</scp> cardiovascular outcome trial
Diabetes Obesity and Metabolism·2023· 4 citedOpen Access
Effects of Ertugliflozin on Kidney Outcomes in Patients With Heart Failure at Baseline in the Evaluation of Ertugliflozin Efficacy and Safety Cardiovascular Outcomes (VERTIS CV) Trial
Kidney International Reports·2023· 1 citedOpen Access
Effects of once‐weekly subcutaneous semaglutide on coronary artery disease outcomes in patients with type 2 diabetes with or at high risk for cardiovascular disease: Insights from the SUSTAIN‐6 trial
Diabetes Obesity and Metabolism·2022· 4 citedOpen Access
Author response for "Effects of Once‐Weekly Subcutaneous Semaglutide on Coronary Artery Disease Outcomes in Patients with Type 2 Diabetes with or at High Risk for Cardiovascular Disease: Insights from the SUSTAIN‐6 Trial"
2022
Author response for "Effects of Once‐Weekly Subcutaneous Semaglutide on Coronary Artery Disease Outcomes in Patients with Type 2 Diabetes with or at High Risk for Cardiovascular Disease: Insights from the SUSTAIN‐6 Trial"
2022
Abstract 12404: Assessment Of Associations Between Hypoglycemia And Cardiovascular Outcomes In The Randomized CARMELINA And CAROLINA Trials Of The Antihyperglycemic Medication Linagliptin
Circulation·2022
Trends in Oral Anticoagulant Use Among 436 864 Patients With Atrial Fibrillation in Community Practice, 2011 to 2020
Journal of the American Heart Association·2022· 162 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Tsuyoshi Kaneko(16), Sameer Hirji(12), Siobhan McGurk(11), Marc Pelletier(11), Darren K. McGuire(11), Jiyae Lee(9), Fernando Ramírez Del Val(8), Ashraf Nabhan(7), Julius I. Ejiofor(7), Rami Doukky(7), Setri Fugar(7), Ann Marie Návar(6), Eric D. Peterson(6), Piotr Sobieszczyk(5), Pinak Shah(5), Ahmed Al‐Ogaili(5), Sary F. Aranki(5), Prem Shekar(5), Ritam Chowdhury(5), Fernando Ramirez‐Del Val(4)